{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T23:09:49Z","timestamp":1721689789932},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":1334,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jfma.2011.02.006","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T08:37:32Z","timestamp":1334997452000},"page":"333-339","source":"Crossref","is-referenced-by-count":8,"title":["Safety and immunogenicity of a split-virion AS03A-adjuvanted A\/Indonesia\/05\/2005 (H5N1) vaccine in Taiwanese adults"],"prefix":"10.1016","volume":"111","author":[{"given":"Pan-Chyr","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamadou","family":"Drame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Walravens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2011.02.006_bib1","unstructured":"World Health Organization. Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO, 18 October 2010. Global alert and response (GAR) [Internet]. Available from: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2010_10_18\/en\/index.html [accessed 9.11.10]."},{"key":"10.1016\/j.jfma.2011.02.006_bib2","first-page":"1","article-title":"Influenza A (H5N1): an overview of the current situation","volume":"14","author":"Melidou","year":"2009","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jfma.2011.02.006_bib3","series-title":"Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. WHO scientific consultation. Geneva, Switzerland","year":"2007"},{"key":"10.1016\/j.jfma.2011.02.006_bib4","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2007.05.033","article-title":"Pre- or post-pandemic influenza vaccine","volume":"25","author":"Osterhaus","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2011.02.006_bib5","unstructured":"United States Food and Drug Administration (USFDA). First \u201cbird flu\u201d vaccine for humans approved [Internet]. Available: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2007\/ucm108892.htm [accessed\u00a008.10.10]."},{"key":"10.1016\/j.jfma.2011.02.006_bib6","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1016\/j.vaccine.2009.07.102","article-title":"Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine. A phase III study in a large population of Asian adults","volume":"27","author":"Chu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2011.02.006_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jfma.2011.02.006_bib8","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","author":"Leroux-Roels","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jfma.2011.02.006_bib9","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.vaccine.2008.02.068","article-title":"Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial","volume":"26","author":"R\u00fcmke","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2011.02.006_bib10","unstructured":"European Committee for Proprietary Medicinal Products. Guideline on influenza vaccine prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (EMEA\/CHMP\/VWP\/263499\/2006). European Agency for the Evaluation of Medicinal Products. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003872.pdf [accessed 9.11.10]."},{"key":"10.1016\/j.jfma.2011.02.006_bib11","unstructured":"FDA Guidance for Industry. Clinical data needed to support the licensure of pandemic influenza vaccines. US Food and\u00a0Drug Administration May 2007 [Internet]. Available: http:\/\/www.fda.gov\/cber\/gdlns\/panfluvac.htm [accessed 15.09.10]."},{"key":"10.1016\/j.jfma.2011.02.006_bib12","unstructured":"Global Alert and Response. Current WHO phase of pandemic alert for avian influenza H5N1 [Internet]. Available: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/phase\/en\/index.html [accessed 12.01.11]."},{"key":"10.1016\/j.jfma.2011.02.006_bib13","unstructured":"Seasonal Flu: International Situation Update. Global Flu Activity Update [Internet]. Available from: http:\/\/www.cdc.gov\/flu\/international\/activity.htm [accessed 12.01.11]."},{"key":"10.1016\/j.jfma.2011.02.006_bib14","unstructured":"World Health Organization. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human\u00a0vaccines [Internet]. Available from: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/guidelines\/201009_H5_H9_VaccineVirusUpdate.pdf [accessed 04.02.11]."},{"key":"10.1016\/j.jfma.2011.02.006_bib15","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1016\/j.vaccine.2009.01.040","article-title":"Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2011.02.006_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2011.02.006_bib17","unstructured":"World Health Organization. Global Alert and Response. Availability of a new recombinant H5N1 vaccine virus, May 2009 [Internet]. Available from: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/H5N1virus26May\/en\/index.html [accessed 18.10.10]."},{"key":"10.1016\/j.jfma.2011.02.006_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1517\/14712590903066695","article-title":"Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data","volume":"9","author":"Lerous-Roels","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jfma.2011.02.006_bib19","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/INF.0b013e3181daf921","article-title":"Immunogenicity and safety of H5N1 A\/Vietnam\/1194\/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase II, randomized, open, controlled study","volume":"29","author":"D\u00edez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664612000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664612000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T14:24:18Z","timestamp":1642083858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664612000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0929664612000447"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2011.02.006","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}